Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Current Pharmaceutical Biotechnology|August 5, 2022
MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug DevelopmentMelisa Çetinkaya, Yusuf BaranAdvances in Experimental Medicine and Biology|October 29, 2024
Mesenchymal Stem Cells in Cancer TherapyZüleyha Baran, Melisa Çetinkaya, Yusuf BaranAdvances in Experimental Medicine and Biology|November 6, 2024
Flavonoids as Chemosensitizers in LeukemiasNigar Huseynova, Melisa Çetinkaya, Züleyha Baran, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2015
Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signalingAysun Adan, Yusuf BaranCritical Reviews in Oncology/Hematology|January 11, 2014
An update on molecular biology of thyroid cancersOzgur Omur, Yusuf BaranComputers in Biology and Medicine|February 12, 2023
scMAGS: Marker gene selection from scRNA-seq data for spatial transcriptomics studiesYusuf Baran, Berat DoğanTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 18, 2015
The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networksAysun Adan, Yusuf BaranJournal of Blood Medicine|November 28, 2012
Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemiaYusuf Baran, Guray SaydamHematology (Amsterdam, Netherlands)|June 4, 2009
Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cellsGozde Gucluler, Yusuf BaranPageof 9